CWM
GSK icon

C2C Wealth Management’s GSK GSK Stock Holding History

C2C Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,820
Closed -$218K – 199
2022
Q1 		$218K Sell
3,820
-354
-8% -$19.2K 0.04% 186
2021
Q4 		$230K Buy
+4,174
New +$217K 0.03% 196

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

C2C Wealth Management's GSK Position: Q2 2022 in Review

C2C Wealth Management sold out of GSK (GSK) in Q2 2022, closing a stake of 3,820 shares — an estimated $218K sold.

C2C Wealth Management first reported a position in GSK in Q4 2021 and held it in 2 quarters. The position peaked at $230K in Q4 2021. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • C2C Wealth Management reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • C2C Wealth Management sold 3,820 GSK shares in Q2 2022, an estimated $218K.
  • C2C Wealth Management first reported a position in GSK in Q4 2021 and held it in 2 quarters.
  • C2C Wealth Management's GSK position peaked at $230K in Q4 2021.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on C2C Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.